Evaluation of the Effect of Leukocyte and Platelet-rich Fibrin on Healing After Periradicular Surgery
1 other identifier
interventional
15
1 country
1
Brief Summary
The aim of this study is to evaluate the effect of two different periapical surgery methods ("curettage+apical resection" and "curettage") on the bone regeneration and clinical healing without applying any material or with applying leukocyte and platelet rich fibrin (L-PRF) to the periradicular intraosseous defect in the treatment of the teeth with large periapical lesions by following the patients for 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2022
CompletedFirst Submitted
Initial submission to the registry
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2024
CompletedFebruary 27, 2026
February 1, 2026
1.1 years
February 1, 2023
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Apical lesion healing
Periapical index score and the dimensions of the periapical radiolucency will be evaluated on the periapical radiographs taken at the control sessions. In addition, pain, swelling, tooth mobility, sensitivity to percussion, sensitivity of palpation and presence of fistula will be evaluated. The PAI is a basic radiographic method of interpretation consisting of a scale from 1 to 5. It was first described by Ørstavik et al in 1986 (14). For each subject, the periapical tissue was assessed radiographically using the PAI as follows: 1. PAI 1: normal periapical structure 2. PAI 2: small changes in the bone structure not pathognomonic of apical periodontitis 3. PAI 3: changes in the bone structure with mineral loss characteristic of apical periodontitis 4. PAI 4: well-defined apical radiolucency characteristic of apical periodontitis 5. PAI 5: severe periodontitis with exacerbating features and bone expansion
an average of 1 year
Study Arms (4)
1. group: Retrograde Filling Group / RG Group
EXPERIMENTALSurgical curettage of the periapical lesion and root tip resection will be performed, MTA will be applied retrogradely and no material will be applied to the bone defect
2. Group: Retrograde Filling+L-PRF Group / RG+L-PRF Group
EXPERIMENTALSurgical curettage of the periapical lesion and root tip resection will be performed, MTA will be applied retrogradely and L-PRF will be applied to the bone defect.
3. Group: Orthograde Filling Group / OG Group
EXPERIMENTALSurgical curettage of the periapical lesion will be performed, MTA will be applied orthogradely without root tip resection and no material will be applied to the bone defect.
4. Group: Orthograde Filling+L-PRF Group / OG+L-PRF Group
EXPERIMENTALSurgical curettage of the periapical lesion will be performed, MTA will be applied orthogradely without root tip resection and L-PRF will be applied to the bone defect.
Interventions
Surgical curettage of the periapical lesion and root tip resection will be performed, MTA will be applied retrogradely and no material will be applied to the bone defect.
2\. Group: Surgical curettage of the periapical lesion and root tip resection will be performed, MTA will be applied retrogradely and L-PRF will be applied to the bone defect (
3\. Group: Surgical curettage of the periapical lesion will be performed, MTA will be applied orthogradely without root tip resection and no material will be applied to the bone defect
4\. Group: Surgical curettage of the periapical lesion will be performed, MTA will be applied orthogradely without root tip resection and L-PRF will be applied to the bone defect
Eligibility Criteria
You may qualify if:
- Being over 18 years old.
- systemic status is ASA I.
- No history of allergy to local anesthetics and drugs to be used. D. Absence of a systemic disease or drug use that may adversely affect wound healing and contraindicate oral surgical procedures (radiotherapy, chemotherapy, corticosteroid use, antiplatelet or anticoagulant drug use, connective tissue diseases, vascular diseases, blood dyscrasia, liver diseases, uncontrolled diabetes, etc.).
- to. Not smoking more than 10 cigarettes per day. f. Having a single rooted tooth of endodontic origin, with a periradicular lesion larger than 5 mm and smaller than 12 mm in diameter detected on periapical radiograph (chronic apical periodontitis), re-canal treatment planned and thought to be unsuccessful with re-canal treatment alone.
You may not qualify if:
- Having ASA II-III-IV.
- Having a history of allergy to local anesthetics and drugs to be used.
- Presence of a systemic disease or drug use that may adversely affect postoperative wound healing and periodontal health.
- D. Being pregnant or lactating. to. Not using antiplatelet or anticoagulant drugs and having blood dyscrasias f. Smoking more than 10 cigarettes per day. g. Vertical root fracture, perforation in the furcation region, endo-perio lesion and more than 5 mm periodontal bone loss in the involved tooth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University, Faculty of Dentistry
Istanbul, Turkey (Türkiye)
Related Publications (1)
Gulsever S, Ersahan S, Hepsenoglu YE, Tekin A. Apicoectomy versus apical curettage in combination with or without L-PRF application: a randomized clinical trial. Sci Rep. 2025 Mar 8;15(1):8121. doi: 10.1038/s41598-025-92787-y.
PMID: 40057596DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SEYDA ERSAHAN, Assoc.Prof.
Medipol University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- director
Study Record Dates
First Submitted
February 1, 2023
First Posted
May 6, 2023
Study Start
February 7, 2022
Primary Completion
March 2, 2023
Study Completion
September 2, 2024
Last Updated
February 27, 2026
Record last verified: 2026-02